Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,409 GBX | +0.40% | +1.99% | +17.06% |
06:21am | HBM Holdings Unit, AstraZeneca Sign License, Option Agreement for Targeted Cancer Treatment; Shares Rise 16% | MT |
May. 22 | Behind the numbers: AstraZeneca aims for sales of $80 billion by 2030 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.06% | 244B | |
+37.74% | 723B | |
+34.36% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+9.78% | 208B | |
-4.38% | 205B | |
+2.81% | 168B | |
+7.43% | 166B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents